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INTRODUCTION: THE DENGUE VACCINE
CONTROVERSY
In 2016, the Philippines embarked on an
unprecedented mass immunisation campaign
against dengue fever, becoming the first Asian
nation to authorise the commercial use of
Dengvaxia, the dengue vaccine manufactured
by the French pharmaceutical Sanofi Pasteur.1
In December 2017, nearly 2 years since the
campaign started, Sanofi announced that
Dengvaxia may actually cause ‘more severe
disease’ in those who have not had previous
dengue infection.2 By then, over 800,000 Filipino schoolchildren had been inoculated.1
Criminal investigations against involved
government figures ensued, with one critic
likening the mass vaccination programme to
a ‘genocide against Filipino children’.3 The
deaths of several children who had received
the vaccine became a focal point of the
scandal, as the Public Attorney’s Office ran
a highly publicised and dramatised investigation, from televised autopsies to the chief
lawyer appearing alongside the grieving
mothers in media interviews.3–5 The resulting
‘crisis of confidence’ against the public health
sector sent immunisation rates plummeting
to an all-
time low, precipitating a measles
outbreak across the country, exacerbating
already-low immunisation rates.5
What went wrong, and how could a
different—or more deliberate—communications strategy have contributed to averting
those mistakes? In this article, we identify
several lessons on health communication
from the dengue vaccine controversy that
may prove beneficial in light of the COVID-19
pandemic, given the emergent parallels
between the two health crises.

TRUST AND CREDIBILITY
Fundamentally, effective health communication entails trust between the public and the

Summary box
►► As countries around the world begin to roll out

COVID-19 vaccines, vaccine safety communication
is more relevant than ever.
►► The dengue vaccine controversy in the Philippines
offers lessons that can be applied to immunisation
programmes being organised today to address the
COVID-19 pandemic.
►► Effective vaccine safety communication entails (re)
building relationships of trust between government
and the public, upholding the credibility of scientific
institutions and maintaining transparency.
►► It also involves viewing health against the broader
framework of equity, using an interdisciplinary approach to health communication and putting a premium on public feedback.

scientific community. Building confidence
in vaccines ‘implies trust in the vaccine (the
product), trust in the vaccinator or other
health professional (the provider), and
trust in those who make the decisions about
vaccine provision (the policy-
maker)’.6 In
other words, trust springs from credibility.
One way to do this is through deference
to non-
partisan, expert institutions and
upholding the credibility of these institutions. In the dengue vaccine controversy, this
was seen in the involvement of the Philippine
General Hospital’s independent panel of
experts who became the de facto unbiased
inquisitors of the sensationalised turn of
events. Unfortunately, though their investigation virtually exonerated the vaccine from the
deaths of the children, these experts had to
compete with many other voices, mostly from
government, that only undermined whatever
authority they may have held during the crisis.
Under COVID-19, the importance of
letting scientific institutions take the lead
in communications cannot be overstated.
These institutions remain our most credible
sources of information; thus, they must lead
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TRANSPARENCY
Related to trust and credibility is transparency, which
entails a consistent effort to disclose necessary information from all parties in any health-
related endeavour.
This means not just being upfront about factual information—the science of newly manufactured vaccines, their
risks and limitations—but also about the circumstances
with which they will be given to an anxious public.
The late disclosure of the dengue vaccine’s potentially life-threatening effects led to accusations of lack
of transparency and widespread speculation that the
programme, with its multibillion-peso funding, was in
reality railroaded by corrupt practices.8 Separately, under
COVID-19, violations of this cardinal rule of transparency
have already transpired in the Philippines even before
public vaccinations have started: in December 2020, it
was discovered that no less than members of the Presidential Security Group had been injected with the yet-to-
be-approved Sinopharm vaccines, smuggled from China;
worse, a black market of illegal vaccinations among
Chinese nationals in the country was apparently being
tolerated by the government.9 10 These situations, instead
of pre-empting feelings of suspicion towards vaccines,
only worsen the public’s mistrust towards their government and, consequently, towards vaccines themselves.
EQUITY
Another important tenet is equity—the vulnerable and
marginalised on equal footing with the privileged. In
the dengue vaccine controversy, a point of inequity was
initially raised by politicians who questioned the selection process for the programme’s implementation; why,
during an election year, certain administrative regions
were supposedly ‘prioritised’ over others.11 Subsequently,
inequity could be seen in the way local government
units—some more resource-
rich than others—were
forced to intervene in the aftermath of the national
communication breakdown.
A year into the COVID-19 pandemic, equity red flags
have been raised again and again—from politicians
flouting quarantine measures, to these same politicians
abusing their authority and disregarding the ‘prioritisation list’ of the vaccination process.12 At the same time,
2

news of numerous highly urbanised cities forging their
own vaccination deals with international pharmaceuticals have raised fears that such undertakings will result
to geographic inequity, with poorer cities and regions
at a disadvantage.13 Equity in vaccine communication
therefore entails looking at vaccination against the
broader public health infrastructure, with clear guidelines, audience segmentation and targeted campaigns
emphasising—and insisting on—universal access to the
vaccines. This will not only streamline COVID-19 vaccinations, but in the long run, even improve coverage rates of
existing vaccines.
PARTICIPATION AND FEEDBACK
Finally, effective health communication means
accounting for participation and feedback. As shown by
the dengue vaccine controversy, ‘expertise’ is not enough
in the face of insufficient ‘buy-in’ from all concerned
sectors, including within the scientific community.
Participation means recognising that vaccine hesitancy—and vaccine safety communication—involves
not just the scientific community but every other institution across political and civil society. Against a predominantly Western framework of science communication,
it will entail synchronous, interdisciplinary engagement
among: primary care workers who know the situation
on the ground (ie, hospital and community settings);
social science and communications experts with the
necessary tools to understand ‘local vaccine culture’—
the root of people’s fears, distrust and (mis)conceptions
regarding vaccines, as well as the healthcare system14–16;
media workers who must ensure that the information
being relayed to the public do not get sensationalised or
distorted; and even religious and civil society groups with
established influence over their communities. Additionally, this will also entail ‘starting young’—integrating and
emphasising the importance of healthcare communications into the training curricula of hospitals and medical
schools.17
Most importantly, participatory communication
means putting a premium on feedback, showing people
that their government is responding to them. With the
dengue vaccine controversy, the failure of government to
preserve feedback mechanisms led to the rise of ‘moral
entrepreneurs’ who manufactured competing narratives
and overwhelmed communication channels, both in
mass and social media.4
However, feedback can also be a means for authorities
to know what the people are thinking—and thinking
incorrectly. Under COVID-19, a vigorous feedback mechanism can pre-empt misinformation and disinformation,
especially online.18 19 This means not just anticipating
occasions of fake news but also occasions to be honest to
the public regarding vaccine risks and failure. Not only
for vaccine communication, but health communications
in general, investing in improving feedback mechanisms
has become an essential—and life-saving—path forward.
Lasco G, Yu VG. BMJ Global Health 2021;6:e005422. doi:10.1136/bmjgh-2021-005422
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without interference—or perceived interference—from
partisan figures. Politicians may help inspire public confidence towards vaccination, but too often they engage in
medical populist tropes, such as passing off unfounded
knowledge claims as facts, that are damaging to the
scientific institutions.3 4 Left unchecked, these political
tactics result in ‘vaccine messianism’, where politicians
overemphasise their faith in vaccines, obscuring what the
scientific community has actually proven thus far,7 And
a public that views vaccines as mere political tools being
wielded by actors in power, as what transpired during the
dengue vaccine controversy, will only end up rejecting a
vaccine, no matter how efficacious.
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CONCLUSION
Vaccine mistrust is not irreversible; a study comparing
vaccine confidence before and after the dengue vaccine
was administered in the Philippines showed that while
confidence levels had indeed plunged, they had also seen
a relative, gradual increase, suggesting that attitudes can
be swayed over time.20
However, as the Philippine experience hopefully makes
clear, especially for countries in similar straits, rebuilding
trust in vaccines, and the healthcare system, is an arduous
road forward, where partnerships between the authorities and the public must be re-established through transparent systems, on top of long-term investments towards
the healthcare infrastructure. Politicisation must be
avoided at all costs, and credible, non-
partisan actors
must be at the forefront of communicating the case
for immunisation. Checks and balances must always be
preserved, which means both the public—including the
medical community—fulfilling its role as active, critical
participants of the healthcare system and the government being accountable at all times for all its actions—
and inactions. Absent such deliberate efforts, any vaccine
produced to stomp the pandemic will only go to waste.

